0001437749-19-018247.txt : 20190911
0001437749-19-018247.hdr.sgml : 20190911
20190911201148
ACCESSION NUMBER: 0001437749-19-018247
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190909
FILED AS OF DATE: 20190911
DATE AS OF CHANGE: 20190911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rice Michael
CENTRAL INDEX KEY: 0001389512
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 191089338
MAIL ADDRESS:
STREET 1: C/O BIOLIFE SOLUTIONS, INC.
STREET 2: 171 FRONT STREET
CITY: OWEGO
STATE: NY
ZIP: 13827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC
CENTRAL INDEX KEY: 0000834365
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 943076866
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4254011400
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLIFE SOLUTION INC
DATE OF NAME CHANGE: 20030113
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
rdgdoc.xml
FORM 4
X0306
4
2019-09-09
0000834365
BIOLIFE SOLUTIONS INC
BLFS
0001389512
Rice Michael
C/O BIOLIFE SOLUTIONS, INC.
3303 MONTE VILLA PARKWAY, SUITE 310
BOTHELL
WA
98021
1
1
President & CEO
Common Stock
2019-09-09
4
M
0
14000
1.121
A
189014
D
Common Stock
2019-09-09
4
S
0
14000
19.43
D
175014
D
Common Stock
2019-09-11
4
M
0
14571
1.121
A
189585
D
Common Stock
2019-09-11
4
S
0
14571
19.36
D
175014
D
Employee Stock Option
1.121
2019-09-09
4
M
0
14000
0
D
2021-02-25
Common Stock
14000
14571
D
Employee Stock Option
1.121
2019-09-11
4
M
0
14571
0
D
2021-02-25
Common Stock
14571
0
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.33 to $19.56, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.30 to $19.41, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Option vested as of the last day of the calendar quarter in which the Company first achieved cash flow break even after the grant date.
/s/ Michael Rice
2019-09-11